Form 4: Treace Medical Concepts CEO John T. Treace Reports Share Disposals and Holdings

Treace Medical Concepts CEO John T. Treace reported the disposal of 11,905 shares for tax purposes and disclosed his beneficial ownership of over 5 million shares through various direct and indirect holdings.

Summary

• John T. Treace, CEO of Treace Medical Concepts, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On January 10, 2025, Mr. Treace disposed of 11,905 shares of common stock to cover tax obligations.
• The disposal was a transaction code 'F' which indicates a disposition to satisfy tax withholding obligations.
• Following the transaction, Mr. Treace directly owns 6,511,190 shares of common stock.
• Mr. Treace also has indirect ownership of 1,605,000 shares through his spouse, 1,471,250 shares through his spouse as trustee of a trust, 1,839,063 shares as trustee of a trust, and 408,816 shares as co-trustee of a trust.
• Mr. Treace disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
• He also disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.
• The report also notes that 151,882 of the directly held shares are restricted stock units.

Sentiment

Score: 5

Explanation: The document is a neutral disclosure of insider transactions, with no indication of positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the holdings of key executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The level of detail provided is typical for these types of disclosures, including the breakdown of direct and indirect ownership.

Stakeholder Impact

• This filing provides transparency to shareholders regarding the holdings of the CEO.
• The transaction is not expected to have a significant impact on the company's operations or financial position.

Key Dates

Keywords

Form 4, Beneficial Ownership, Insider Trading, Stock Disposal, Treace Medical Concepts, TMCI, John T. Treace, Restricted Stock Units